- Home
- BPMC vs OLED Comparison
BPMC vs OLED Comparison
Compare BPMC & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- OLED
- Stock Information
- Founded
- BPMC 2008
- OLED 1985
- Country
- BPMC United States
- OLED United States
- Employees
- BPMC N/A
- OLED N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- OLED Semiconductors
- Sector
- BPMC Health Care
- OLED Technology
- Exchange
- BPMC Nasdaq
- OLED Nasdaq
- Market Cap
- BPMC 6.7B
- OLED 7.2B
- IPO Year
- BPMC 2015
- OLED 1992
- Fundamental
- Price
- BPMC $111.96
- OLED $150.09
- Analyst Decision
- BPMC Buy
- OLED Strong Buy
- Analyst Count
- BPMC 19
- OLED 7
- Target Price
- BPMC $122.72
- OLED $207.86
- AVG Volume (30 Days)
- BPMC 789.4K
- OLED 647.1K
- Earning Date
- BPMC 02-13-2025
- OLED 02-20-2025
- Dividend Yield
- BPMC N/A
- OLED 1.06%
- EPS Growth
- BPMC N/A
- OLED 15.56
- EPS
- BPMC N/A
- OLED 4.98
- Revenue
- BPMC $434,415,000.00
- OLED $643,711,000.00
- Revenue This Year
- BPMC $108.09
- OLED $12.60
- Revenue Next Year
- BPMC $39.34
- OLED $11.48
- P/E Ratio
- BPMC N/A
- OLED $30.20
- Revenue Growth
- BPMC 100.93
- OLED 9.63
- 52 Week Low
- BPMC $72.24
- OLED $143.25
- 52 Week High
- BPMC $121.90
- OLED $237.00
- Technical
- Relative Strength Index (RSI)
- BPMC 71.32
- OLED 44.79
- Support Level
- BPMC $103.67
- OLED $146.19
- Resistance Level
- BPMC $107.88
- OLED $151.29
- Average True Range (ATR)
- BPMC 4.24
- OLED 4.08
- MACD
- BPMC 2.43
- OLED 0.74
- Stochastic Oscillator
- BPMC 97.93
- OLED 43.68
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.